Advancing treatment options for influenza: challenges with the human influenza challenge

J Infect Dis. 2015 Apr 1;211(7):1033-5. doi: 10.1093/infdis/jiu543. Epub 2014 Oct 3.

Authors

Alicia M Fry¹, Weimin Zhong¹, Larisa V Gubareva¹

Affiliation

¹ Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

PMID: 25281756
DOI: 10.1093/infdis/jiu543

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Female
Humans
Immunologic Factors / therapeutic use*
Influenza A Virus, H3N2 Subtype / immunology*
Influenza, Human / drug therapy*
Male
Oseltamivir / administration & dosage*

Substances

Antibodies, Monoclonal
Immunologic Factors
Oseltamivir